questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Hémoprotéines
Cytochromes
Cytochrome P-450 enzyme system
Famille-2 de cytochromes P450
Limonène hydroxylases
Limonène hydroxylases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Interrupted Time Series Analysis
Diagnostic
5
Déficience enzymatique
Tests génétiques
Tests biochimiques
Activité enzymatique
Symptômes
Dysfonction enzymatique
Tests génétiques
Mutations
Symptômes
5
Troubles métaboliques
Réactions allergiques
Éruptions cutanées
Hypersensibilité
Troubles neurologiques
Symptômes
Prévention
5
Alimentation équilibrée
Nutriments
Tests génétiques
Surveillance précoce
Environnement de travail
Exposition
Traitements
5
Traitements symptomatiques
Modifications diététiques
Thérapie génique
Recherche
Thérapies alternatives
Gestion des symptômes
Complications
5
Complications métaboliques
Réactions allergiques
Risques à long terme
Maladies chroniques
Complications neurologiques
Cas rares
Facteurs de risque
5
Antécédents familiaux
Expositions environnementales
Facteurs environnementaux
Produits chimiques
Mode de vie
Complications
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Limonène hydroxylases : Questions médicales les plus fréquentes",
"headline": "Limonène hydroxylases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Limonène hydroxylases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-17",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Limonène hydroxylases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Famille-2 de cytochromes P450",
"url": "https://questionsmedicales.fr/mesh/D000072467",
"about": {
"@type": "MedicalCondition",
"name": "Famille-2 de cytochromes P450",
"code": {
"@type": "MedicalCode",
"code": "D000072467",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.422.220.453.491"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cytochrome P-450 CYP2C9",
"alternateName": "Cytochrome P-450 CYP2C9",
"url": "https://questionsmedicales.fr/mesh/D065729",
"about": {
"@type": "MedicalCondition",
"name": "Cytochrome P-450 CYP2C9",
"code": {
"@type": "MedicalCode",
"code": "D065729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.422.220.453.491.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cytochrome P-450 CYP2C19",
"alternateName": "Cytochrome P-450 CYP2C19",
"url": "https://questionsmedicales.fr/mesh/D065731",
"about": {
"@type": "MedicalCondition",
"name": "Cytochrome P-450 CYP2C19",
"code": {
"@type": "MedicalCode",
"code": "D065731",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.422.220.453.491.500.700"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Limonène hydroxylases",
"alternateName": "Limonene Hydroxylases",
"code": {
"@type": "MedicalCode",
"code": "D065730",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sasa Liu",
"url": "https://questionsmedicales.fr/author/Sasa%20Liu",
"affiliation": {
"@type": "Organization",
"name": "College of Enology, Northwest A&F University, Yangling, Shaanxi, 712100, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Yuyao Ren",
"url": "https://questionsmedicales.fr/author/Yuyao%20Ren",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Biotechnology, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, 116023, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Guojie Jin",
"url": "https://questionsmedicales.fr/author/Guojie%20Jin",
"affiliation": {
"@type": "Organization",
"name": "College of Enology, Northwest A&F University, Yangling, Shaanxi, 712100, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Xiaobing Yang",
"url": "https://questionsmedicales.fr/author/Xiaobing%20Yang",
"affiliation": {
"@type": "Organization",
"name": "College of Enology, Northwest A&F University, Yangling, Shaanxi, 712100, People's Republic of China. yangxb@nwafu.edu.cn."
}
},
{
"@type": "Person",
"name": "Elham Zarenezhad",
"url": "https://questionsmedicales.fr/author/Elham%20Zarenezhad",
"affiliation": {
"@type": "Organization",
"name": "Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Universal HIV screening in the emergency department: an interrupted time series analysis.",
"datePublished": "2022-06-22",
"url": "https://questionsmedicales.fr/article/35730396",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/QAD.0000000000003282"
}
},
{
"@type": "ScholarlyArticle",
"name": "Trauma team leader and early mortality: An interrupted time series analysis.",
"datePublished": "2022-10-07",
"url": "https://questionsmedicales.fr/article/36244124",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajem.2022.09.048"
}
},
{
"@type": "ScholarlyArticle",
"name": "Suicide among soldiers and social contagion effects: An interrupted time-series analysis.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36746079",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.socscimed.2023.115747"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of the economic recession on suicide mortality in Brazil: interrupted time series analysis.",
"datePublished": "2022-06-10",
"url": "https://questionsmedicales.fr/article/35703676",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0034-7167-2021-0778"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health worker protests and the COVID-19 pandemic: an interrupted time-series analysis.",
"datePublished": "2024-07-04",
"url": "https://questionsmedicales.fr/article/39219771",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2471/BLT.23.290330"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hémoprotéines",
"item": "https://questionsmedicales.fr/mesh/D006420"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cytochromes",
"item": "https://questionsmedicales.fr/mesh/D003580"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cytochrome P-450 enzyme system",
"item": "https://questionsmedicales.fr/mesh/D003577"
},
{
"@type": "ListItem",
"position": 7,
"name": "Famille-2 de cytochromes P450",
"item": "https://questionsmedicales.fr/mesh/D000072467"
},
{
"@type": "ListItem",
"position": 8,
"name": "Limonène hydroxylases",
"item": "https://questionsmedicales.fr/mesh/D065730"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Limonène hydroxylases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Limonène hydroxylases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Limonène hydroxylases",
"description": "Comment diagnostiquer une déficience en limonène hydroxylases ?\nQuels tests sont utilisés pour évaluer l'activité des limonène hydroxylases ?\nLes symptômes peuvent-ils indiquer un problème avec les limonène hydroxylases ?\nY a-t-il des biomarqueurs associés aux limonène hydroxylases ?\nComment les tests génétiques aident-ils au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D065730?mesh_terms=Interrupted+Time+Series+Analysis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Limonène hydroxylases",
"description": "Quels symptômes sont liés à une déficience en limonène hydroxylases ?\nLes symptômes varient-ils selon les individus ?\nPeut-on observer des symptômes cutanés ?\nLes symptômes respiratoires sont-ils fréquents ?\nY a-t-il des symptômes neurologiques associés ?",
"url": "https://questionsmedicales.fr/mesh/D065730?mesh_terms=Interrupted+Time+Series+Analysis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Limonène hydroxylases",
"description": "Peut-on prévenir les troubles liés aux limonène hydroxylases ?\nY a-t-il des mesures diététiques préventives ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nL'éducation sur les allergies est-elle importante ?\nLes environnements de travail peuvent-ils influencer la santé ?",
"url": "https://questionsmedicales.fr/mesh/D065730?mesh_terms=Interrupted+Time+Series+Analysis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Limonène hydroxylases",
"description": "Quels traitements sont disponibles pour les troubles liés aux limonène hydroxylases ?\nLa thérapie génique est-elle une option ?\nDes médicaments spécifiques existent-ils ?\nComment la nutrition peut-elle aider ?\nLes traitements alternatifs sont-ils efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D065730?mesh_terms=Interrupted+Time+Series+Analysis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Limonène hydroxylases",
"description": "Quelles complications peuvent survenir avec une déficience en limonène hydroxylases ?\nLes complications sont-elles réversibles ?\nY a-t-il des risques à long terme ?\nLes complications affectent-elles la qualité de vie ?\nDes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D065730?mesh_terms=Interrupted+Time+Series+Analysis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Limonène hydroxylases",
"description": "Quels sont les facteurs de risque pour les troubles enzymatiques ?\nL'âge influence-t-il le risque de déficience ?\nLes allergies augmentent-elles le risque ?\nY a-t-il des facteurs environnementaux à considérer ?\nLe mode de vie joue-t-il un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D065730?mesh_terms=Interrupted+Time+Series+Analysis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en limonène hydroxylases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des limonène hydroxylases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques mesurant l'activité enzymatique dans des échantillons biologiques."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils indiquer un problème avec les limonène hydroxylases ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes métaboliques peuvent suggérer une dysfonction enzymatique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs associés aux limonène hydroxylases ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des métabolites spécifiques peuvent servir de biomarqueurs pour l'activité enzymatique."
}
},
{
"@type": "Question",
"name": "Comment les tests génétiques aident-ils au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils identifient des mutations dans les gènes codant pour les limonène hydroxylases."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une déficience en limonène hydroxylases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles métaboliques, des réactions allergiques ou des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'expression des symptômes peut varier en fonction de la génétique et de l'environnement."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes cutanés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées peuvent survenir en raison d'une hypersensibilité."
}
},
{
"@type": "Question",
"name": "Les symptômes respiratoires sont-ils fréquents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme l'asthme peuvent être exacerbés par des métabolites du limonène."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques peuvent survenir, mais ils sont moins fréquents."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux limonène hydroxylases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais éviter les allergènes peut aider à réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures diététiques préventives ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en nutriments peut soutenir la santé enzymatique."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier les individus à risque et permettre une surveillance précoce."
}
},
{
"@type": "Question",
"name": "L'éducation sur les allergies est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre les allergies peut aider à éviter les déclencheurs et réduire les risques."
}
},
{
"@type": "Question",
"name": "Les environnements de travail peuvent-ils influencer la santé ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des environnements de travail exposant à des terpènes peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles liés aux limonène hydroxylases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements symptomatiques et des modifications diététiques peuvent être recommandés."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore largement disponible pour ces troubles."
}
},
{
"@type": "Question",
"name": "Des médicaments spécifiques existent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de médicaments spécifiques pour traiter ces déficiences."
}
},
{
"@type": "Question",
"name": "Comment la nutrition peut-elle aider ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut soutenir la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Les traitements alternatifs sont-ils efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies alternatives peuvent aider à gérer les symptômes, mais peu de preuves."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une déficience en limonène hydroxylases ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications métaboliques et des réactions allergiques sévères peuvent se produire."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des risques de maladies chroniques peuvent augmenter en raison de l'exposition continue."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent significativement impacter la qualité de vie des individus concernés."
}
},
{
"@type": "Question",
"name": "Des complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, bien que rares, des complications neurologiques peuvent survenir dans certains cas."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles enzymatiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux et des expositions environnementales peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de déficience ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines déficiences peuvent se manifester plus tard dans la vie."
}
},
{
"@type": "Question",
"name": "Les allergies augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes allergiques peuvent être plus susceptibles de développer des troubles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à considérer ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des produits chimiques et à des terpènes peut être un facteur de risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque de complications liées aux enzymes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
College of Enology, Northwest A&F University, Yangling, Shaanxi, 712100, People's Republic of China.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Biotechnology, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, 116023, People's Republic of China.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
College of Enology, Northwest A&F University, Yangling, Shaanxi, 712100, People's Republic of China.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
College of Enology, Northwest A&F University, Yangling, Shaanxi, 712100, People's Republic of China. yangxb@nwafu.edu.cn.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran. m.osanloo@fums.ac.ir.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
Department of Energy Conversion and Storage, Faculty of Chemistry, Gdańsk University of Technology, G. Narutowicza 11/12, PL-80-233 Gdańsk, Poland.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
Institute of Fluid-Flow Machinery, Polish Academy of Sciences, Fiszera 14 st., PL-80-231 Gdańsk, Poland.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
School of Food Engineering, Department of Food Science, University of Campinas, Campinas, Brazil.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, California 92093, USA. vhgrassian@ucsd.edu.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of California, Irvine, California 92697, USA. dtobias@uci.edu.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of California, Irvine, California 92697, USA. dtobias@uci.edu.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, California 92093, USA. vhgrassian@ucsd.edu.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical and Biological Engineering, Northwestern University, Evanston, IL, USA.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical and Biological Engineering, Northwestern University, Evanston, IL, USA.
Publications dans "Limonène hydroxylases" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical and Biological Engineering, Northwestern University, Evanston, IL, USA.
Chemistry of Life Processes Institute, Northwestern University, Evanston, IL, USA.
Center for Synthetic Biology, Northwestern University, Evanston, IL, USA.
Robert H. Lurie Comprehensive Cancer Center, Simpson Querrey Institute Northwestern University, Chicago, IL, USA.
Simpson Querrey Institute Northwestern University, Chicago, IL, USA.
Publications dans "Limonène hydroxylases" :
1 publication dans cette catégorie
Affiliations :
DECHEMA-Forschungsinstitut, Industrial Biotechnology, Frankfurt am Main, Germany.
Faculty Biological Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany.
Publications dans "Limonène hydroxylases" :
1 publication dans cette catégorie
Affiliations :
DECHEMA-Forschungsinstitut, Industrial Biotechnology, Frankfurt am Main, Germany.
Publications dans "Limonène hydroxylases" :
1 publication dans cette catégorie
Affiliations :
DECHEMA-Forschungsinstitut, Industrial Biotechnology, Frankfurt am Main, Germany.
Publications dans "Limonène hydroxylases" :
1 publication dans cette catégorie
Affiliations :
Faculty Biological Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany.
Publications dans "Limonène hydroxylases" :
We performed a calendar-matched, 12-month, before (November 27, 2017 to November 26, 2018) and after (November 27, 2018 to November 26, 2019) study, to assess the utility of an emergency department-ba...
The trauma team leader (TTL) is a "model" of a specifically dedicated team leader in the emergency department (ED), but its benefits are uncertain. The primary objective was to assess the impact of th...
Major trauma admissions (Injury Severity Score (ISS)≥12) in 3 Canadian Level-1 trauma centres were included from 2003 to 2017. The TTL program was implemented in centre 1 in 2005. An interrupted time ...
TTL implementation was not associated with changes in mortality or admission delays from the ED. Future studies should assess the potential impact of TTL programs on other patient-centred outcomes usi...
Suicide has become an increasingly concerning problem among soldiers in recent years. Previous research has hypothesized that media-related social contagion effects, termed "Werther effects," may cont...
An interrupted time-series analysis, relying on annual military suicide rates between 1873 and 1910, indicated a significant increase in the suicide rate the year of Rudolf's death, a pattern consiste...
Although we are very careful when interpreting causal effects with our historical data, we discuss the latter finding by questioning whether a change in military culture, that is, the establishment of...
to analyze trends in suicide rates in Brazil in the period before and after the start of the economic recession....
interrupted time series research using national suicide data recorded in the period between 2012 and 2017 with socioeconomic subgroups analyses. Quasi-Poisson regression model was employed to analyze ...
there was an abrupt increase in the risk of suicide after economic recession in the population with less education (12.5%; RR = 1.125; 95%CI: 1.027; 1.232) and in the South Region (17.7%; 1.044; 1.328...
the Brazilian economic recession caused different effects on suicide rates, considering social strata, which requires health strategies and policies that are sensitive to the most vulnerable populatio...
To assess the impact of the coronavirus disease 2019 (COVID-19) pandemic on protests by health workers....
We conducted an interrupted time series analysis of data from 159 countries for 2 years before and after the World Health Organization classified COVID-19 as a pandemic in March 2020, thus between 201...
In total, there were 18 322 health worker protests in 133 countries between 2018 and 2022. The number of weekly health worker protests globally increased by 47% (30.1/63.5), an increase of 30.1 protes...
The pandemic increased the overall level of health worker protests globally as well as the number of countries experiencing such protests. These protests highlight discontent in the health workforce. ...
We are sometimes forced to use the Interrupted Time Series (ITS) design as an identification strategy for potential policy change, such as when we only have a single treated unit and cannot obtain com...
We hypothesized that children with Down syndrome who were born after the implementation of first-trimester combined screening for trisomy 13, 18, and 21 and a second-trimester ultrasound scan in Denma...
A nationwide register-based study of all live born singletons with Down syndrome in Denmark from 1995 to 2018. In interrupted time series analyses, we studied the temporal developments in birth biomet...
We included 602 singletons with Down syndrome born before and 308 after implementation of the screening program. Z-scores of birthweight and head circumference increased over time before screening, bu...
After implementation of a national prenatal screening program, we did not observe a milder Down syndrome phenotype apart from an apparent reduction in the proportion of children with non-severe congen...
In Australia, the available published literature demonstrated a spike in dispensed prescription medicines after the onset of the COVID-19 pandemic that subsequently returned to expected levels. Smokin...
Australia's universal health-care system provides access to government-subsidised medicines via the Pharmaceutical Benefits Scheme and records of dispensed medicines are publicly available on a nation...
After an initial spike in medicines at the onset of the pandemic, the monthly rate of prescriptions dispensed for varenicline was predominantly within predicted ranges, while that of NRT patches was p...
There has been a differential change in the number of subsidised smoking cessation medicines supplied in Australia since the COVID-19 pandemic, with varenicline prescriptions largely within, and NRT p...
To evaluate the seasonality of acute bronchiolitis in Brazil during the 2020-2022 season and compare it with the previous seasons....
Data from the incidence of hospitalizations due to acute bronchiolitis in infants <1 year of age were obtained from the Department of Informatics of the Brazilian Public Health database for the period...
Compared to the pre-COVID-19 period, the incidence of hospitalizations related to acute bronchiolitis decreased by 97% during non-pharmacological interventions (March 2020 - August 2021) but increased...
This study underscores the significant influence of COVID-19 interventions on acute bronchiolitis hospitalizations in Brazil. The restoration of a seasonal pattern in 2022 highlights the interplay bet...
The aim of this study is to reveal the impact of the COVID-19 pandemic, which constitutes an extraordinary situation, on the habits of emergency health service use. The data of the study consist of em...